| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $108.5M | +13.5% | +31.2% |
| Cost of Revenue | $43.9M | +11.7% | +34.5% |
| Gross Profit | $64.6M | +14.9% | +29.0% |
| R&D Expense | $61.5M | +2.9% | +5.2% |
| SG&A Expense | $19.4M | +4.9% | +12.9% |
| Operating Income | -$16.2M | +26.1% | +36.3% |
| Pre-tax Income | -$14.2M | +28.2% | +39.5% |
| Income Tax | $933K | +268.8% | +43.1% |
| Net Income | -$15.1M | +24.4% | +37.2% |
| EPS (Basic) | -$0.35 | +25.5% | +39.7% |
| EPS (Diluted) | -$0.35 | +25.5% | +39.7% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $174.1M | +21.9% | +36.9% |
| Accounts Receivable | $42.2M | -1.6% | +24.3% |
| Inventory | $39.2M | +15.8% | +7.0% |
| Current Assets | $383.7M | +11.6% | +26.4% |
| Total Assets | $751.9M | +6.4% | +12.1% |
| Current Liabilities | $144.5M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $54.6M | — | — |
| Investing Cash Flow | -$26.1M | — | — |
| Financing Cash Flow | $1.4M | — | — |
| +35.2% |
| Total Liabilities | $161.8M | +24.5% | +38.9% |
| Stockholders' Equity | $590.1M | +2.4% | +6.5% |